DC
Decoy Therapeutics Inc. (DCOY)
NASDAQ·Healthcare·Biotechnology
$5.48
-0.64%
Mkt Cap $4.58M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q2 2026 Apr 3, 2026 | — | — | — | -$6.48 | -$6.48 | +0.00% | — | — |
| Q4 2025 Nov 14, 2025 | — | — | — | -$33.60 | -$1.81 | +94.61% | — | — |
| Q3 2025 Aug 12, 2025 | — | — | — | -$33.00 | -$6.75 | +79.55% | — | — |
| Q2 2025 May 14, 2025 | — | — | — | -$36.00 | -$15.44 | +57.11% | — | — |
| Q1 2025 Mar 21, 2025 | — | — | — | -$34.65 | -$9.90 | +71.43% | — | — |
| Q4 2024 Nov 14, 2024 | — | — | — | -$2.40 | -$11.39 | -374.58% | — | — |
| Q3 2024 Aug 9, 2024 | — | — | — | -$803.60 | -$35.53 | +95.58% | — | — |
| Q2 2024 May 13, 2024 | — | — | — | -$803.60 | -$49.18 | +93.88% | — | — |
| Q1 2024 Mar 22, 2024 | — | — | — | -$121.14 | -$26.39 | +78.22% | — | — |
| Q4 2023 Nov 9, 2023 | — | — | — | -$128.34 | -$77.96 | +39.26% | — | — |
| Q3 2023 Aug 10, 2023 | — | — | — | -$151.12 | -$171.51 | -13.49% | — | — |
| Q2 2023 May 11, 2023 | — | — | — | -$237.48 | -$267.47 | -12.63% | — | — |
| Q1 2023 Mar 27, 2023 | — | — | — | -$248.28 | -$339.43 | -36.71% | — | — |
| Q4 2022 Nov 10, 2022 | — | — | — | -$341.83 | -$296.25 | +13.33% | — | — |
| Q3 2022 Aug 8, 2022 | — | — | — | -$329.84 | -$269.87 | +18.18% | — | — |
| Q2 2022 May 12, 2022 | — | — | — | -$2.25 | -$389.81 | -17224.89% | — | — |
| Q1 2022 Mar 10, 2022 | $325.00K | -$1.84M | -666.22% | -$299.85 | -$269.87 | +10.00% | — | — |
| Q4 2021 Nov 4, 2021 | $1.16M | — | — | -$269.87 | -$239.88 | +11.11% | — | — |
| Q3 2021 Aug 5, 2021 | $571.00K | $571.39K | +0.07% | -$179.91 | -$209.90 | -16.67% | — | — |
| Q2 2021 May 12, 2021 | $1.37M | $1.27M | -7.38% | -$1.25 | -$179.91 | -14292.80% | — | — |